g******0
发帖数: 1165 | 1 After-Hours Movers 7/22: HWAY, ALGN, INFN, ETFC, ATHN, CMG, CYMI Higher;
AMZN, BOOT, QLGC, ACTG, INPH, MCRL, SNDK Lower
Jul 22, 2010 05:44PM
Healthways (Nasdaq: HWAY) 21.4% HIGHER; reports Q2 EPS of $0.29, 2 cents
better than the analyst estimate of $0.27. Revenue for the quarter was $175.
5 million, which compares to the estimate of $176.82 million. Sees Q3 EPS $0
.26-$0.29, versus $0.29. FY10 1.07-$1.18, versus the consensus of $1.12.
Amazon.com (Nasdaq: AMZN) 13.9% LOWER; reports Q2 EPS of $0.46, versus the
analyst estimate of $0.55. Revenue for the quarter was $6.57 billion, which
compares to the estimate of $6.54 billion. Sees Q3 sales of $6.9-$7.625
billion, vs. cons. of $7.17 billion. Sees operating income of $210-$310
million.
Lacrosse Footwear Inc. (Nasdaq: BOOT) 12% LOWER; reports Q2 EPS of $0.02, 20
cents below the analyst estimate of $0.22. Revenue for the quarter was $26.
6 million, which compares to the estimate of $32.1 million.
Align Tech (Nasdaq: ALGN) 11.7% HIGHER; reports Q2 EPS of $0.21, 7 cents
better than the analyst estimate of $0.14. Revenue for the quarter was $93.9
million, which compares to the estimate of $89.82 million. Sees Q3 EPS of $
0.16-$0.18, versus the consensus of $0.14. Sees Q3 sales of $92-$95 million,
versus the consensus of $89.6 million.
QLogic (Nasdaq: QLGC) 10.9% LOWER; reports Q1 EPS of $0.30, 1 cent better
than the analyst estimate of $0.29. Revenue for the quarter was $142.6
million, which compares to the estimate of $144.07 million.
Acacia Research (Nasdaq: ACTG) 8.9% LOWER; reports Q2 loss of $0.12, versus
the analyst estimate of $0.07. Revenue for the quarter was $15.0 million,
which compares to the estimate of $19.00 million.
Infinera (Nasdaq: INFN) 8% HIGHER; reports Q2 EPS of $0.03, ex-items, 9
cents better than the analyst estimate of ($0.06). Revenue for the quarter
was $111.4 million, which compares to the estimate of $100.12 million.
E*TRADE (Nasdaq: ETFC) 7% HIGHER; reports Q2 EPS of $0.12, 23 cents better
than the analyst estimate of ($0.11). Revenue for the quarter was $534
million.
AthenaHealth (Nasdaq: ATHN) 6.5% HIGHER; reports Q2 adjusted EPS of $0.12, 2
cents better than the analyst estimate of $0.10. Revenue for the quarter
was $58.6 million, which compares to the estimate of $59.20 million.
Interphase Corp. (Nasdaq: INPH) 6.3% LOWER; reports Q2 loss of $0.32, versus
$0.01 gain last year. Revenue for the quarter was $ 3.9million, which
compares to $8.1 million last year.
Chipotle Mexican Grill (NYSE: CMG) 6% HIGHER; reports Q2 EPS of $1.46, 7
cents better than the analyst estimate of $1.39. Revenue for the quarter was
$466.8 million, which compares to the estimate of $452.84 million.
Micrel (Nasdaq: MCRL) 6% LOWER; reports Q2 EPS of $0.21, in-line with the
analyst estimate of $0.21. Revenue for the quarter was $73.9 million, which
compares to the estimate of $76.72 million. Sees Q3 sales up 5-8%
SanDisk (Nasdaq: SNDK) 4.5% LOWER; reports Q2 adjusted EPS of $1.08, versus
the analyst estimate of $0.90. Revenue for the quarter was $1.18 billion,
which compares to the estimate of $1.16 billion.
Cymer (Nasdaq: CYMI) 4.1% HIGHER; reports Q2 EPS of $0.70, 17 cents better
than the analyst estimate of $0.53. Revenue for the quarter was $131.9
million, which compares to the estimate of $117.62 million. Sees Q3 sales of
$132-$138 million, versus the consensus of 132.4 million.
BJ Restaurants (Nasdaq: BJRI) 4% LOWER; reports Q2 EPS of $0.23, 3 cents
better than the analyst estimate of $0.20. Revenue for the quarter was $130.
5 million, which compares to the estimate of $127.15 million. Same store
sales up 5.3%
Lattice Semiconductor Corporation (Nasdaq: LSCC) 4% LOWER; reports Q2 EPS of
$0.14, 2 cents better than the analyst estimate of $0.12. Revenue for the
quarter was $77.1 million, which compares to the estimate of $76.1 million.
Skyworks (Nasdaq: SWKS) 4% LOWER; reports Q3 adjusted EPS of $0.32, 2 cents
better than the analyst estimate of $0.30. Revenue for the quarter was $275.
4 million, which compares to the estimate of $269.44 million. Sees Q4 sales
of about $300 million, versus the consensus of $287.5 million. Also sees Q4
EPS about $0.37, versus $0.34 consensus.
Informatica (Nasdaq: INFA) 3.5% HIGHER; reports Q2 adjusted EPS of $0.25, 2
cents better than the analyst estimate of $0.23. Revenue for the quarter was
$155.7 million, which compares to the estimate of $143.65 million.
Riverbed Technology (Nasdaq: RVBD) 3.5% HIGHER; reports Q2 EPS of $0.25, 3
cents better than the analyst estimate of $0.22. Revenue for the quarter was
$126.2 million, which compares to the estimate of $119.38 million.
Capital One (NYSE: COF) 3.5% LOWER; reports Q2 operating EPS of $1.78,
versus the analyst estimate of $0.86 and $1.40 reported for the same period
last year. Revenue for the quarter was $3.9 billion, which compares to the
estimate of $3.96 billion.
Electronics For Imaging (Nasdaq: EFII) 3.4% HIGHER; reports Q2 EPS of $0.09,
ex-items, 3 cents better than the analyst estimate of $0.06. Revenue for
the quarter was $119.1 million, which compares to the estimate of $112.00
million.
Penson Worldwide (Nasdaq: PNSN) 3.3% LOWER; reports Q2 adj-loss of $0.03,
which may not compare to the analyst estimate of $0.06. Revenue for the
quarter was $71.11 million, which compares to the estimate of $71.13 million.
Cheesecake Factory (Nasdaq: CAKE) 3.2% LOWER; reports Q2 EPS of $0.36, 1
cents better than the analyst estimate of $0.38. Revenue for the quarter was
$418.3 million, which compares to the estimate of $419.63 million.
Seacoast Banking (Nasdaq: SBCF) 3% LOWER; reports Q2 adj-loss of $0.25,
versus the analyst estimate of ($0.09).
American Express (NYSE: AXP) 1.5% LOWER; reports Q2 EPS of $0.84, 7 cents
better than the analyst estimate of $0.77.
Rambus (Nasdaq: RMBS) 1.3% LOWER; reports Q2 loss of $0.11, compared to the
analyst estimate of ($0.07). Revenue for the quarter was $38.9 million,
which compares to the estimate of $39.10 million.
J&J Snack Foods (Nasdaq: JJSF) 1% LOWER; reports Q3 EPS of $0.85, versus the
analyst estimate of $0.88. Revenue for the quarter was $189.7 million,
which compares to the estimate of $191.90 million.
Immucor (Nasdaq: BLUD) 1% LOWER; reports Q4 EPS of $0.30, 1 cents better
than the analyst estimate of $0.29. Revenue for the quarter was $82.9
million, which compares to the estimate of $82.28 million. Reaffirms FY11 |
|
